Your browser doesn't support javascript.
loading
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.
Willenbacher, Ella; Jöhrer, Karin; Willenbacher, Wolfgang; Flögel, Brigitte; Greil, Richard; Kircher, Brigitte.
Affiliation
  • Willenbacher E; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
  • Jöhrer K; Tyrolean Cancer Research Institute, Innsbruck, Austria.
  • Willenbacher W; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
  • Flögel B; Oncotyrol, Center for Personalized Cancer Medicine, Innsbruck, Austria.
  • Greil R; Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.
  • Kircher B; Tyrolean Cancer Research Institute, Innsbruck, Austria.
Ann Hematol ; 98(11): 2569-2578, 2019 Nov.
Article in En | MEDLINE | ID: mdl-31628518

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Plasma Cell / Isoquinolines / Multiple Myeloma / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Austria Country of publication: Alemania

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Plasma Cell / Isoquinolines / Multiple Myeloma / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Austria Country of publication: Alemania